These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29406112)
1. Inhibition of thrombin by functionalized C Liu Y; Fu J; Pan W; Xue Q; Liu X; Zhang A J Environ Sci (China); 2018 Jan; 63():285-295. PubMed ID: 29406112 [TBL] [Abstract][Full Text] [Related]
2. Competitive Inhibition Mechanism of Acetylcholinesterase without Catalytic Active Site Interaction: Study on Functionalized C Liu Y; Yan B; Winkler DA; Fu J; Zhang A ACS Appl Mater Interfaces; 2017 Jun; 9(22):18626-18638. PubMed ID: 28492309 [TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures. Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780 [TBL] [Abstract][Full Text] [Related]
4. Interaction of fullerene nanoparticles with biomembranes: from the partition in lipid membranes to effects on mitochondrial bioenergetics. Santos SM; Dinis AM; Peixoto F; Ferreira L; Jurado AS; Videira RA Toxicol Sci; 2014 Mar; 138(1):117-29. PubMed ID: 24361870 [TBL] [Abstract][Full Text] [Related]
5. Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors. Turabekova M; Rasulev B; Theodore M; Jackman J; Leszczynska D; Leszczynski J Nanoscale; 2014 Apr; 6(7):3488-95. PubMed ID: 24548972 [TBL] [Abstract][Full Text] [Related]
6. Interaction Principle Between Coagulation Factor X and Fullerene Derivatives with Different Hydrophilic-Hydrophobic Properties for Anticoagulation. Liu J; Liu R; Li L; Wang X; Gao X; Xing G; Jiang H; Zhao L J Nanosci Nanotechnol; 2019 Aug; 19(8):4603-4610. PubMed ID: 30913755 [TBL] [Abstract][Full Text] [Related]
7. Silver and fullerene nanoparticles' effect on interleukin-2-dependent proliferation of CD4 (+) T cells. Côté-Maurais G; Bernier J Toxicol In Vitro; 2014 Dec; 28(8):1474-81. PubMed ID: 25172299 [TBL] [Abstract][Full Text] [Related]
8. Effects of fullerene C₆₀ nanoparticles on A549 cells. Wang F; Jin C; Liang H; Tang Y; Zhang H; Yang Y Environ Toxicol Pharmacol; 2014 Mar; 37(2):656-61. PubMed ID: 24577232 [TBL] [Abstract][Full Text] [Related]
9. The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors. Saleh NA Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt C():1523-9. PubMed ID: 25459714 [TBL] [Abstract][Full Text] [Related]
10. Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Baker GL; Gupta A; Clark ML; Valenzuela BR; Staska LM; Harbo SJ; Pierce JT; Dill JA Toxicol Sci; 2008 Jan; 101(1):122-31. PubMed ID: 17878152 [TBL] [Abstract][Full Text] [Related]
11. Theoretical investigations on C60 -ionic liquid interactions and their impacts on C60 dispersion behavior. Wang Z; Tang L; Peijnenburg WJ Environ Toxicol Chem; 2014 Aug; 33(8):1802-8. PubMed ID: 24764219 [TBL] [Abstract][Full Text] [Related]
12. C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase II alpha. Baweja L; Gurbani D; Shanker R; Pandey AK; Subramanian V; Dhawan A J Biomed Nanotechnol; 2011 Feb; 7(1):177-8. PubMed ID: 21485859 [TBL] [Abstract][Full Text] [Related]